ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BIEL Bioelectronics Corp (PK)

0.0002
0.00 (0.00%)
29 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Bioelectronics Corp (PK) USOTC:BIEL OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0002 0.0001 0.0003 0.0002 0.0001 0.0002 16,359,150 21:30:03

BioElectronics CEO Honored by Chabad at Johns Hopkins Medicine

13/03/2013 9:04am

OTC Markets










BioElectronics CEO Honored by Chabad at Johns Hopkins Medicine


/* Style Definitions */
span.prnews_span
{
font-size:8pt;
font-family:"Arial";
color:black;
}
a.prnews_a
{
color:blue;
}
li.prnews_li
{
font-size:8pt;
font-family:"Arial";
color:black;
}
p.prnews_p
{
font-size:0.62em;
font-family:"Arial";
color:black;
margin:"0in";
}










BioElectronics CEO Honored by Chabad at Johns Hopkins Medicine

Andrew J. Whelan Received Prestigious National Humanitarian Technology Leadership Award by Chabad at Johns Hopkins Medicine

PR Newswire











FREDERICK, Md., March 13, 2013 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of consumer medical devices, today announced that its CEO, Andrew J. Whelan, was awarded the prestigious National Humanitarian Technology Leadership Award by Chabad at Johns Hopkins.




"We chose to honor Mr. Whelan because of his personal philanthropy and his leadership in bringing to market a breakthrough medical product," said Brian Gelman, development director of Chabad at Johns Hopkins.




The award was presented at the 10th anniversary Grand Annual Community Dinner on Tuesday, March 12 at the Johns Hopkins University in Baltimore.  Other award recipients at the evening's gala include global leaders in health-care, Dr. Paul Rothman, Dean of the Medical Faculty and CEO of Johns Hopkins Medicine, and Dr. Jeremy Levin and Allan Oberman, respectively, President and CEO of Teva Pharmaceuticals and CEO of Teva Americas Generics, the world's largest producer of generic drugs.





About BioElectronics Corporation

Drugs and heat patches provide temporary minimal pain relief by simply masking it but it always comes back.  ActiPatch provides 5x better pain relief and is 100% safer than over-the-counter drugs. BioElectronics Corporation is an award winning medical device developer and manufacturer of advanced medical devices.  Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal complaints, the Allay™ menstrual cycle pain therapy, and RecoveryRx™ for surgical procedures and wound care and HealFast® Therapy veterinarian line.  The unique therapy delivery system, using patented technology, provides a cost-effective in-home option to reduce soft tissue pain and inflammation, and to accelerate healing. For more information, please see www.bielcorp.com.





About Chabad at Johns Hopkins


Chabad at Johns Hopkins, an affiliate of Chabad Lubavitch, the world's largest Jewish educational and social service organization, is a community-support organization, which supports patients and students at Johns Hopkins. 





Media contacts:

For BioElectronics

Paul Knopick, E&E Communications
940-262-3584





For Chabad Hopkins

Brian Gelman, Development Director, Chabad at Johns Hopkins

410-861-0770



SOURCE BioElectronics Corporation











1 Year Bioelectronics (PK) Chart

1 Year Bioelectronics (PK) Chart

1 Month Bioelectronics (PK) Chart

1 Month Bioelectronics (PK) Chart